Olivia Goldhill and Meghana Keshavan

BioTech

FDA rejects MDMA as a psychedelic treatment for PTSD

The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on Friday, in a blow to drug activists and veterans who’ve

Olivia Goldhill and Meghana Keshavan August 9, 2024

BioTech

Tracking the FDA advisory panel on MDMA therapy for PTSD

Good morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific advisory committee meeting to review safety and efficacy data for

Olivia Goldhill and Meghana Keshavan June 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Olivia Goldhill and Meghana Keshavan

FDA rejects MDMA as a psychedelic treatment for PTSD

Tracking the FDA advisory panel on MDMA therapy for PTSD

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe